CNSY (CNSY) FinancialsCNSYCNSY

Evaluating the bottom line, Cerenome, Inc maintains a gross margin of 100.00%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -2203.65%, while the net margin is -2191.24%. These profitability ratios, combined with a Return on Equity (ROE) of -614.05%, provide a clear picture of how effectively CNSY converts its operational activities into shareholder value.

In the context of the broader market, CNSY competes directly with industry leaders such as GNTA and BFRI. With a market capitalization of $22.31M, it holds a significant position in the sector. When comparing efficiency, CNSY's gross margin of 100.00% stands against GNTA's N/A and BFRI's 79.92%. Such benchmarking helps identify whether Cerenome, Inc is trading at a premium or discount relative to its financial performance.

The company has reported significant net losses, with a net income of -9006000 in Q2 2026 and a negative EPS of -1.31. Furthermore, the gross margin remains at 100%, but this does not compensate for the overall negative financial outlook.